Pfizer says COVID-19 pill near 90% effective in final analysis

13 Sept 07:37 Key points summarised by AI

Pfizer's COVID-19 antiviral pill, Paxlovid, achieved nearly 90% efficacy in preventing hospitalizations and deaths in high-risk patients, with recent lab data confirming its effectiveness against the Omicron variant.
The final analysis showed no deaths in the treatment group, contrasting with 12 deaths among placebo recipients, and also demonstrated a 70% reduction in hospitalizations for standard-risk adults.
Regulatory authorization from the U.S. FDA and other agencies for use in high-risk individuals is anticipated soon, with the drug expected to significantly save lives and prevent hospitalizations.
Paxlovid is poised to generate substantial revenue and offers a superior oral antiviral treatment compared to rival Merck's molnupiravir, which showed only 30% efficacy.

Speculation growing over merger between Bhumjaithai and Kla Tham parties

Today 16:46 Key points summarised by AI

A dinner between Bhumjaithai and Kla Tham party leaders sparked rumors of a potential merger, though Bhumjaithai's leader, Anutin, downplayed it as a casual meal.
The meeting is widely interpreted as a strategic message from Bhumjaithai to the Pheu Thai party, signaling alternative support ahead of an upcoming no-confidence debate.
Thailand's Constitution (Section 99) currently prohibits direct mergers of parties with sitting MPs during the House's term, a rule designed to prevent the 'buying and selling' of MPs.
While direct mergers are restricted, MPs can still switch parties if dismissed by a three-fourths party vote or if their party dissolves, allowing for indirect political realignments.
Kla Tham's voting behavior in the censure debate will demonstrate its loyalty to the government, potentially influencing future political dynamics despite current merger restrictions.